The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

To date, most new vaccines against Mycobacterium tuberculosis, including new recombinant versions of the current BCG vaccine, have usually been screened against the laboratory strains H37Rv or Erdman. In this study we took advantage of our recent work in characterizing an increasingly large panel of...

Descripción completa

Detalles Bibliográficos
Autores principales: Henao-Tamayo, Marcela, Shanley, Crystal A., Verma, Deepshikha, Zilavy, Andrew, Stapleton, Margaret C., Furney, Synthia K., Podell, Brendan, Orme, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569086/
https://www.ncbi.nlm.nih.gov/pubmed/26368806
http://dx.doi.org/10.1371/journal.pone.0136500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569086/
https://www.ncbi.nlm.nih.gov/pubmed/26368806
http://dx.doi.org/10.1371/journal.pone.0136500

Ejemplares similares